Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v17-FR Version v12-FR
Language French French
Date Updated 2024-04-11 2024-01-10
Drug Identification Number 02244379 02244379
Brand name PROPOFOL INJECTION PROPOFOL INJECTION
Common or Proper name Propofol Injection Propofol Injection
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients PROPOFOL PROPOFOL
Strength(s) 10MG 10MG
Dosage form(s) EMULSION EMULSION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size AIN00003 (100 mL) AIN00003 (100 mL)
ATC code N01AX N01AX
ATC description ANESTHETICS, GENERAL ANESTHETICS, GENERAL
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date 2024-05-01 2024-05-01
Actual start date
Estimated end date Unknown
Actual end date 2024-04-11
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status Yes No
Company comments Product remains available. Baxter continues to work to mitigate any potential supply risk. Contact your Baxter Pharmacy representative for additional information. Product remains available. Baxter continues to work to mitigate any potential supply risk. Contact your Baxter Pharmacy representative for additional information.
Health Canada comments